Abstract
Understanding which features drive the treatment effect has long been a complex and critical question in clinical decision-making. Significant advances have been made in estimating treatment effects, particularly with Conditional Average Treatment Effect (CATE) models. These models account for confounding variables, e.g. age, and gender, thereby capturing heterogeneity in treatment effects. However, identifying the specific features driving these effects remains largely unexplored. To bridge these gaps, we propose CODE-XAI, a framework that interprets CATE models using Explainable AI (XAI) to perform feature discovery. CODE-XAI provides feature attribution at individual and cohort levels, enhancing our understanding of treatment responses. We benchmark these XAI methods using real-world clinical data, demonstrating their effectiveness in uncovering feature contributions and enabling cross-cohort analysis, advancing precision medicine and scientific discovery.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The survey data for this study was gathered under an exempt determination from the University of Washington Institutional Review Board (Human Subjects Division, STUDY00006890). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* indicates co-senior authorship
* Introduction * Discussion * Figure/notation errors
1 For each feature, we aggregated the absolute values of local attributions across all individuals in the cohort and took the average to obtain the global (cohort) explanation.
2 A lower interaction p-value indicates a higher likelihood of a feature being a treatment effect modifier.
Data Availability
All data except UW Harborview data are available online at the below links
https://biolincc.nhlbi.nih.gov/home/
https://freebird.lshtm.ac.uk/index.php/available-trials/
